524711 VISTAPH

Vista Pharmaceuticals Share Price

₹11.63 -0.47 (-3.88%)

23 Dec, 2024 09:05

SIP TrendupStart SIP in VISTAPH

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month -0.34%
  • Over 3 Month -12.09%
  • Over 6 Month -6.74%
  • Over 1 Year -27.85%
SIP Lightning

Smart Investing Starts Here Start SIP with Vista Pharmaceuticals for Steady Growth!

Invest Now

Vista Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Vista Pharmaceuticals Financials

Vista Pharmaceuticals Technicals

EMA & SMA

Current Price
₹11.63
-0.47 (-3.88%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹11.79
  • 50 Day
  • ₹12.14
  • 100 Day
  • ₹12.60
  • 200 Day
  • ₹13.05

Resistance and Support

11.8 Pivot Speed
  • R3 12.66
  • R2 12.43
  • R1 12.03
  • S1 11.40
  • S2 11.17
  • S3 10.77

What's your outlook on Vista Pharmaceuticals?

You can only vote for once

Vista Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-13 Quarterly Results
2024-08-13 Quarterly Results
2024-05-28 Audited Results
2024-02-10 Quarterly Results
2023-11-10 Quarterly Results

Vista Pharmaceuticals F&O

Vista Pharmaceuticals Shareholding Pattern

No data available.

About Vista Pharmaceuticals

  • NSE Symbol
  • VISTAPH
  • BSE Symbol
  • 524711
  • ISIN
  • INE427C01021

Similar Stocks to Vista Pharmaceuticals

Vista Pharmaceuticals FAQs

Vista Pharmaceuticals share price is ₹11 As on 23 December, 2024 | 08:51

The Market Cap of Vista Pharmaceuticals is ₹53.1 Cr As on 23 December, 2024 | 08:51

The P/E ratio of Vista Pharmaceuticals is -15.8 As on 23 December, 2024 | 08:51

The PB ratio of Vista Pharmaceuticals is 1.3 As on 23 December, 2024 | 08:51

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23